Calyxo has secured $40 million in Series F funding, led by Ally Bridge Group and Janus Henderson Investors, marking a significant milestone as 40,000 patients have now been treated with their CVAC System. This funding will likely fuel further expansion and adoption of their aspiration-based kidney stone removal technology. Questa Capital, Avidity Partners, and CRG also participated in the round.
